/clinical/,/clinical/pted/,/clinical/pted/hffy/,/clinical/pted/hffy/cancer/,

/clinical/pted/hffy/cancer/6000.hffy

201707194

page

100

UWHC,UWMF,

Clinical Hub,Patient Education,Health and Nutrition Facts For You,Cancer, BMT, Hematology

Cetuximab (Erbitux) for the Treatment of Cancer (6000)

Cetuximab (Erbitux) for the Treatment of Cancer (6000) - Clinical Hub, Patient Education, Health and Nutrition Facts For You, Cancer, BMT, Hematology

6000


Cetuximab (Erbitux)
For the Treatment of Cancer

Description
EGFR (Epidermal (skin) Growth Factor
Receptor) is found on the surface of cells
and helps control cell growth by binding
(joining) with certain proteins. It is found
on many normal cells and some cancer cells.
Cetuximab is an EGFR Inhibitor. It slows
(inhibits) the growth of some cancer cells.

How is it given
Cetuximab is injected into the vein over 1-2
hours

Common side effects
▪ Acne like rash on face and body –these
symptoms usually develop within the
first two weeks of therapy. Other skin
symptoms may include peeling, redness,
itchy and dry skin. Y ou will receive a
handout with skin care recommendations
- Skin, Nail and Hair Changes HFFY
#7124
▪ Abdominal distress such as nausea,
vomiting, or diarrhea
▪ Fatigue
▪ Changes in finger or toe nails, or the
skin around the nails
▪ Hair changes such as thinning, change in
texture
▪ Eyelashes may grow long and curly
▪ Low Magnesium levels-your blood work
will be monitored frequently for this.

Uncommon side effects
▪ Allergic reaction may occur

Call your Health Care Provider if you
Develop
▪ Fever of 100.8 θF or greater
▪ Symptoms of an allergic reaction such
as:
o Rash
o Flushing
o Itching or hives
o New or increased difficulty breathing
Special Concerns
▪ You may need to take medicines before
receiving Cetuximab to help prevent an
allergic reaction.
▪ Allergic reaction may include: difficulty
in breathing, wheezing, flushing and/or
itchy skin. Report any of these
symptoms to your doctor or nurse
right away
▪ You must take proper precautions to
prevent pregnancy for yourself or any
sexual partners during treatment and for
a period of time once treatment is
completed.













Reproduced, with permission, from the 1989-
2011 United States Pharmacopeial Convention,
Inc.








Your health care team may have given you this
information as part of your care. If so, please use
it and call if you have any questions. If this
information was not given to you as part of your
care, please check with your doctor. This is not
medical advice. This is not to be used for
diagnosis or treatment of any medical condition.
Because each person’s health needs are
different, you should talk with your doctor or
others on your health care team when using this
information. If you have an emergency, please
call 911. Copyright © 7/2017. University of
Wisconsin Hospitals and Clinics Authority. All
rights reserved. Produced by the Department of
Nursing. HF#6000